![Adipogen/Z-Leu-Leu-Leu-CHO [MG-132]/AG-CP3-0011-M001/1 mg](https://www.ebiomall.cn/images/adipogen/ag-cp3-0011.png)
Adipogen/Z-Leu-Leu-Leu-CHO [MG-132]/AG-CP3-0011-M001/1 mg
商品编号：
AG-CP3-0011-M001
品牌：
Adipogen Inc
市场价：
¥300.00
美元价：
180.00
产品分类：
其他试剂
公司分类：
Other_reagents
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Product Details | |
|---|---|
| Synonyms | Z-LLL-CHO; Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal; MG132 |
| Product Type | Chemical |
| Properties | |
| Formula | C26H41N3O5 |
| MW | 475.6 |
| Sequence | Z-Leu-Leu-Leu-aldeyhde |
| CAS | 133407-82-6 |
| RTECS | OH2824610 |
| Purity Chemicals | ≥97% (HPLC) |
| Appearance | White solid. |
| Solubility | Soluble in DMSO or ethanol. |
| InChi Key | TZYWCYJVHRLUCT-VABKMULXSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Keep cool and dry. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
- Potent, cell permeable and selective, reversible proteasome inhibitor [2, 7].
- Blocks degradation of short-lived proteins and induces a heat shock response [2, 6, 7].
- NF-κB activation inhibitor through IκB degradation [3, 8].
- Cell permeable, reversible peptide aldehyde inhibitor. Calpain and cathepsin inhibitor [4, 11].
- Has anticancer properties by inducing cell cycle arrest and activating apoptosis in various cancer cell lines [8, 9, 12,13,15].
- Has adjuvant/chemosensitizer potential [8].
- Neurite outgrowth stimulator in PC12 cells [1].
- Prevents β-secretase cleavage [5, 10].
- Autophagy activator [12, 14].
Product References
- Isolation and characterization of possible target proteins responsible for neurite outgrowth induced by a tripeptide aldehyde in PC12H cells: Y. Saito, et al.; BBRC 184, 419 (1992)
- Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules: K.L. Rock, et al.; Cell 78, 761 (1994)
- The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B: V.J. Palombella, et al.; Cell 78, 773 (1994)
- Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine: S. Tsubuki, et al.; J. Biochem. 119, 572 (1996)
- The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities: H. Klafki, et al.; J. Biol. Chem. 271, 28655 (1996)
- Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance: K.T. Bush, et al.; J. Biol. Chem. 272, 9086 (1997)
- Proteasome inhibitors: valuable new tools for cell biologists: D.H. Lee & A.L. Goldberg; Trends Cell Biol. 8, 397 (1998)
- Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin: A. Arlt, et al.; Oncogene 20, 859 (2001)
- Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination: D. Banerjee & A. Liefshitz; Anticancer Res. 21, 3941 (2001)
- The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase: M.L. Steinhilb, et al.; J. Biol. Chem. 276, 4476 (2001)
- The proteasome inhibitor MG132 protects against acute pancreatitis: T. Letoha, et al.; Free Radic. Biol. Med. 39, 1142 (2005)
- Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells: W.K. Wu, et al.; BBRC 374, 258 (2008)
- Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach: M. Vivier, et al.; J. Med. Chem. 51, 1043 (2008)
- Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems: V.I. Korolchuk, et al.; FEBS Lett. 584, 1393 (2010)
- MG132, a proteasome inhibitor, induces apoptosis in tumor cells: N. Guo & Z. Peng; Asia Pac. J. Clin. Oncol. 9, 6 (2013)
- AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70: M. Centrone, et al.; Cell Physiol. Biochem. 44, 515 (2017)
品牌介绍
Adipogen公司由三个子公司组成，分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国，运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发，如癌症、免疫、炎症、代谢疾病（糖尿病、肥胖）、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外，也可提供抗体和蛋白产品，Adipogen拥有自己的化学实验室，致力于开发创新型小分子化合物。
联络我们
